v3.21.1
Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenues, net $ 15,271 $ 1,888
Cost of revenues 6,344 1,473
Gross profit 8,927 415
Operating expenses:    
Diagnostic expenses 3,809
General and administration 3,782 1,168
Research and development 115 59
Total operating expenses 7,706 1,227
Income (loss) from operations 1,221 (812)
Interest income, net 87 3
Interest expense (251)
Net income (loss) 1,057 (809)
Other comprehensive loss:    
Unrealized gain (loss) on marketable debt securities (11) 11
Total comprehensive income (loss) $ 1,046 $ (798)
Earnings (loss) per share:    
Basic $ 0.07 $ (0.07)
Diluted $ 0.06 $ (0.07)
Weighted average common shares outstanding:    
Basic 14,563,000 11,582,000
Diluted 18,200,000 11,582,000

Source